Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Morland

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Medicine|May 14, 2023
18F-FDG primary tumor uptake to improve N status prediction in cT1 non-metastatic non-small cell lung cancer: development and validation of a positron emission tomography modelDavid Morland, Marco Chiappetta, Pierre-Emmanuel Falcoz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 11, 2024
EANM position paper on challenges and opportunities of full-ring 360° CZT bone imaging: it's time to let go of planar whole-body bone imagingRichard Graham, David Morland, Sarah Cade, et al.
Medicine|January 10, 2023
Predicting subacute hematological toxicity of 177Lu-DOTATATE therapy using healthy organs' uptake on post-treatment quantitative SPECT: A pilot studyDavid Morland, Elizabeth Katherine Anna Triumbari, Christopher Hoog, et al.
Annals of Nuclear Medicine|May 25, 2021
18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphomaDavid Morland, Ghali Zizi, François Godard, et al.
Annals of Nuclear Medicine|March 30, 2026
Multicenter evaluation of commercial AI for [<sup>18</sup>F]FDG PET/CT lesion detectionMaxence Gambiez, Xavier Palard-Novello, Clémence Guéry, et al.
Medicine|January 9, 2020
Added value of 18F-fluorocholine positron emission tomography-computed tomography in presurgical localization of hyperfunctioning parathyroid glands after dual tracer subtraction scintigraphy failure: A retrospective study of 47 patientsDavid Morland, Paul Lalire, Sophie Deguelte, et al.
Clinical Nuclear Medicine|September 15, 2021
Dual-Time-Point 18F-Fluorocholine PET/CT Improves Characterization of Thyroid Nodules in Patients Referred for Primary Hyperparathyroidism: A Proof of Concept StudyJacob Bani, David Morland, Fabrice Hubelé, et al.
Hematological Oncology|May 22, 2025
Investigating the Association Between a Continuous Variable and a Time-To-Event Outcome: Going Beyond the Cut-Off ApproachTesla Murairi Mirimo, Cédric Portugues, Laurent Remontet, et al.
Endocrine|September 30, 2019
Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumorsMaximilien Minon, Clothilde Soriano, David Morland, et al.
Annals of Hematology|January 14, 2025
The predictive power of <sup>18</sup>F-FDG PET/CT two-lesions radiomics and conventional models in classical Hodgkin's Lymphoma: a comparative retrospectively-validated studyElizabeth Katherine Anna Triumbari, David Morland, Roberto Gatta, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Medicine|May 14, 2023
18F-FDG primary tumor uptake to improve N status prediction in cT1 non-metastatic non-small cell lung cancer: development and validation of a positron emission tomography modelDavid Morland, Marco Chiappetta, Pierre-Emmanuel Falcoz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 11, 2024
EANM position paper on challenges and opportunities of full-ring 360° CZT bone imaging: it's time to let go of planar whole-body bone imagingRichard Graham, David Morland, Sarah Cade, et al.
Medicine|January 10, 2023
Predicting subacute hematological toxicity of 177Lu-DOTATATE therapy using healthy organs' uptake on post-treatment quantitative SPECT: A pilot studyDavid Morland, Elizabeth Katherine Anna Triumbari, Christopher Hoog, et al.
Annals of Nuclear Medicine|May 25, 2021
18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphomaDavid Morland, Ghali Zizi, François Godard, et al.
Annals of Nuclear Medicine|March 30, 2026
Multicenter evaluation of commercial AI for [<sup>18</sup>F]FDG PET/CT lesion detectionMaxence Gambiez, Xavier Palard-Novello, Clémence Guéry, et al.
Medicine|January 9, 2020
Added value of 18F-fluorocholine positron emission tomography-computed tomography in presurgical localization of hyperfunctioning parathyroid glands after dual tracer subtraction scintigraphy failure: A retrospective study of 47 patientsDavid Morland, Paul Lalire, Sophie Deguelte, et al.
Clinical Nuclear Medicine|September 15, 2021
Dual-Time-Point 18F-Fluorocholine PET/CT Improves Characterization of Thyroid Nodules in Patients Referred for Primary Hyperparathyroidism: A Proof of Concept StudyJacob Bani, David Morland, Fabrice Hubelé, et al.
Hematological Oncology|May 22, 2025
Investigating the Association Between a Continuous Variable and a Time-To-Event Outcome: Going Beyond the Cut-Off ApproachTesla Murairi Mirimo, Cédric Portugues, Laurent Remontet, et al.
Endocrine|September 30, 2019
Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumorsMaximilien Minon, Clothilde Soriano, David Morland, et al.
Annals of Hematology|January 14, 2025
The predictive power of <sup>18</sup>F-FDG PET/CT two-lesions radiomics and conventional models in classical Hodgkin's Lymphoma: a comparative retrospectively-validated studyElizabeth Katherine Anna Triumbari, David Morland, Roberto Gatta, et al.
Pageof 8